These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35352102)

  • 21. Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.
    Molina JM; Ghosn J; Assoumou L; Delaugerre C; Algarte-Genin M; Pialoux G; Katlama C; Slama L; Liegeon G; Beniguel L; Ohayon M; Mouhim H; Goldwirt L; Spire B; Loze B; Surgers L; Pavie J; Lourenco J; Ben-Mechlia M; Le Mestre S; Rojas-Castro D; Costagliola D;
    Lancet HIV; 2022 Aug; 9(8):e554-e562. PubMed ID: 35772417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV treatment-as-prevention and its effect on incidence of HIV among cisgender gay, bisexual, and other men who have sex with men in Australia: a 10-year longitudinal cohort study.
    Callander D; McManus H; Gray RT; Grulich AE; Carr A; Hoy J; Donovan B; Fairley CK; Holt M; Templeton DJ; Liaw ST; McMahon JH; Asselin J; Petoumenos K; Hellard M; Pedrana A; Elliott J; Keen P; Costello J; Keane R; Kaldor J; Stoové M; Guy R
    Lancet HIV; 2023 Jun; 10(6):e385-e393. PubMed ID: 37068498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low incidence and prevalence of hepatitis C in two cohorts of HIV pre-exposure prophylaxis adherence interventions in men who have sex with men in Southern California.
    Hassan A; Agustin HGS; Burke L; Kofron R; Corado K; Bolan R; Landovitz RJ; Dubé MP; Morris SR
    J Viral Hepat; 2022 Jul; 29(7):529-535. PubMed ID: 35357767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in Attitudes to and the Use of HIV Pre-exposure Prophylaxis by Australian Gay and Bisexual Men, 2011-2017: Implications for Further Implementation from a Diffusion of Innovations Perspective.
    Holt M; Lea T; Bear B; Halliday D; Ellard J; Murphy D; Kolstee J; de Wit J
    AIDS Behav; 2019 Jul; 23(7):1939-1950. PubMed ID: 30539496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors Associated With Willingness to Use Daily Antibiotics as Sexually Transmitted Infection Prophylaxis Among HIV Preexposure Prophylaxis-Experienced Gay and Bisexual Men in Australia.
    Arapali T; Grulich AE; Heywood AE; Chan C; Fraser D; Zablotska IB; Holt M; Vaccher SJ; Bavinton BR
    Sex Transm Dis; 2023 Mar; 50(3):144-149. PubMed ID: 36730780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cost-effectiveness of case-finding strategies for achieving hepatitis C elimination among men who have sex with men in the UK.
    Macgregor L; Ward Z; Martin NK; Nicholls J; Desai M; Hickson F; Weatherburn P; Hickman M; Vickerman P
    J Viral Hepat; 2021 Jun; 28(6):897-908. PubMed ID: 33759257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
    BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Willingness to Take PrEP and Potential for Risk Compensation Among Highly Sexually Active Gay and Bisexual Men.
    Grov C; Whitfield TH; Rendina HJ; Ventuneac A; Parsons JT
    AIDS Behav; 2015 Dec; 19(12):2234-44. PubMed ID: 25735243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sexually Acquired Hepatitis C Infection in HIV-Uninfected Men Who Have Sex With Men Using Preexposure Prophylaxis Against HIV.
    Price JC; McKinney JE; Crouch PC; Dillon SM; Radix A; Stivala A; Carollo JR; Fierer DS
    J Infect Dis; 2019 Apr; 219(9):1373-1376. PubMed ID: 30462305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in Human Immunodeficiency Virus and Sexually Transmitted Infection Testing Among Gay, Bisexual, and Other Men Who Have Sex With Men After Rapid Scale-up of Preexposure Prophylaxis in Victoria, Australia.
    Ryan KE; Asselin J; Fairley CK; Armishaw J; Lal L; Nguyen L; Murphy D; Traeger M; Hellard M; Hoy J; Stoové M; Wright E;
    Sex Transm Dis; 2020 Aug; 47(8):516-524. PubMed ID: 32658175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
    Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L;
    Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low HIV drug resistance prevalence among recently diagnosed HIV-positive men who have sex with men in a setting of high PrEP use.
    King JM; Giallonardo FD; Shaik A; McGregor S; Yeung JYK; Sivaruban T; Lee FJ; Cunningham P; Dwyer DE; Nigro SJ; Grulich AE; Kelleher AD
    J Int AIDS Soc; 2024 Jul; 27(7):e26308. PubMed ID: 39034597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and Prevalence of Hepatitis C Virus Among HIV-Negative Gay and Bisexual Men Using HIV Pre-exposure Prophylaxis (PrEP): A Systematic Review and Meta-analysis.
    Traeger MW; Harney BL; Sacks-Davis R; van Santen DK; Cornelisse VJ; Wright EJ; Hellard ME; Doyle JS; Stoové MA
    Open Forum Infect Dis; 2023 Aug; 10(8):ofad401. PubMed ID: 37593532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and Correlates of Sexually Transmitted Infections Among Black Men Who Have Sex With Men Participating in the HIV Prevention Trials Network 073 Preexposure Prophylaxis Study.
    Hightow-Weidman LB; Magnus M; Beauchamp G; Hurt CB; Shoptaw S; Emel L; Piwowar-Manning E; Mayer KH; Nelson LE; Wilton L; Watkins P; Whitfield D; Fields SD; Wheeler D
    Clin Infect Dis; 2019 Oct; 69(9):1597-1604. PubMed ID: 30615169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overcoming barriers to HIV pre-exposure prophylaxis (PrEP) coverage in Australia among Medicare-ineligible people at risk of HIV: results from the MI-EPIC clinical trial.
    Chan C; Fraser D; Vaccher S; Yeung B; Jin F; Amin J; Dharan NJ; Carr A; Ooi C; Vaughan M; Holden J; Power C; Grulich AE; Bavinton BR;
    Sex Health; 2022 Jan; 18(6):453-459. PubMed ID: 34895427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Levels of Prevention-Effective Adherence to HIV PrEP: An Analysis of Substudy Data From the EPIC-NSW Trial.
    Bavinton BR; Vaccher S; Jin F; Prestage GP; Holt M; Zablotska-Manos IB; Guy R; Amin J; Templeton DJ; Yeung B; Hammoud MA; Lewis D; Baker D; Dharan N; McNulty AM; Grulich AE;
    J Acquir Immune Defic Syndr; 2021 Aug; 87(4):1040-1047. PubMed ID: 33852503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NZPrEP Demonstration Project: protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) to determine feasibility, acceptability, adverse and behavioural effects of PrEP provision to gay and bisexual men in publicly funded sexual health clinics in Auckland, New Zealand.
    Azariah S; Saxton P; Franklin R; Forster R; Werder S; Jenkins R
    BMJ Open; 2019 Jun; 9(6):e026363. PubMed ID: 31248921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States.
    Hosek SG; Landovitz RJ; Kapogiannis B; Siberry GK; Rudy B; Rutledge B; Liu N; Harris DR; Mulligan K; Zimet G; Mayer KH; Anderson P; Kiser JJ; Lally M; Brothers J; Bojan K; Rooney J; Wilson CM
    JAMA Pediatr; 2017 Nov; 171(11):1063-1071. PubMed ID: 28873128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can Australia Reach the World Health Organization Hepatitis C Elimination Goal by 2025 Among Human Immunodeficiency Virus-positive Gay and Bisexual Men?
    Boettiger DC; Salazar-Vizcaya L; Dore GJ; Gray RT; Law MG; Callander D; Lea T; Rauch A; Matthews GV
    Clin Infect Dis; 2020 Jan; 70(1):106-113. PubMed ID: 30816916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.